Risa Kagan - Concepedia

Author

Risa Kagan

University of California, San Francisco ORCID

Also Known As

J Gallagher, R J Kagan, R KAGAN, R Kagan, R. J. Kagan, R. Kagan, RISA KAGAN, Risa Kagan

Publications

3.3K

Citations

H-Index

Concepts

All Affiliations

University of California, San Francisco Bone Health and Osteoporosis Foundation Columbia University George Washington University TherapeuticsMD (United States)

About

Risa Kagan is an author at University of California, San Francisco specializing in medicine, women's health, and osteoporosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	1.3K
2	Endocrinology	2	2	77
3	Public Health	1	1	101
4	Social Sciences	1	1	226
5	Critical Care Medicine	1	1	18

Risa Kagan

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
Treatment With Once-Weekly Alendronate 70 mg Compared With Once-Weekly Risedronate 35 mg in Women With Postmenopausal Osteoporosis: A Randomized Double-Blind Study Clifford J. Rosen, Marc C. Hochberg, Sydney Lou Bonnick, Journal of Bone and Mineral Research	2005	337
Burden of Illness for Osteoporotic Fractures Compared With Other Serious Diseases Among Postmenopausal Women in the United States Andrea Singer, Alex Exuzides, Leslie Spangler, Mayo Clinic Proceedings Bone DiseaseSkeletal TraumaBone HealthOsteoporotic Fractures ComparedMedicine	2014	336
Efficacy of tissue-selective estrogen complex of bazedoxifene/conjugated estrogens for osteoporosis prevention in at-risk postmenopausal women Robert S. Lindsay, John C. Gallagher, Risa Kagan, Fertility and Sterility Bone DiseaseAt-risk Postmenopausal WomenGynecologyBreast CancerMenopause	2009	228
Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: consensus recommendations from The North American Menopause Society and The International Society for the Study of Women's Sexual Health Stephanie S. Faubion, Lisa Larkin, Cynthia A. Stuenkel, Menopause The Journal of The North American Menopause Society Breast OncologyVaginal Hormone TherapiesCancer ManagementGynecologyMenopausal Hormone Therapy	2018	226
A randomized, placebo- and active-controlled trial of bazedoxifene/conjugated estrogens for treatment of moderate to severe vulvar/vaginal atrophy in postmenopausal women Risa Kagan, R. Stanley Williams, Kaijie Pan, Menopause The Journal of The North American Menopause Society	2010	189
Goal-Directed Treatment for Osteoporosis: A Progress Report From the ASBMR-NOF Working Group on Goal-Directed Treatment for Osteoporosis Steven R. Cummings, Felicia Cosman, E. Michael Lewiecki, Journal of Bone and Mineral Research OsteopathyFracture DiagnosticsAmerican SocietySurgeryOsteoporosis	2016	159
Comparison of Weekly Treatment of Postmenopausal Osteoporosis with Alendronate<i>Versus</i>Risedronate Over Two Years Sydney Lou Bonnick, Kenneth G. Saag, Douglas P. Kiel, The Journal of Clinical Endocrinology & Metabolism	2006	144
A cross-sectional study of bone turnover markers in healthy premenopausal women Anne E. de Papp, Henry G. Bone, Michael P. Caulfield, Bone Bone Turnover MarkersBone HealthReproductive HealthGynecologyMaternal Health	2007	101
Osteoporosis management in post-menopausal women. E S Christenson, Xuezhi Jiang, Risa Kagan, PubMed Bone DiseaseOsteoporosis TreatmentBone HealthSevere OsteoporosisGynecology	2012	77
Efficacy of Tissue-Selective Estrogen Complex of Bazedoxifene/Conjugated Estrogens for Osteoporosis Prevention in At-Risk Postmenopausal Women Robert S. Lindsay, John C. Gallagher, Risa Kagan, Obstetrical & Gynecological Survey Hormonal ContraceptiveGynecologyMenopausal Hormone TherapyPharmacotherapySelective Serms	2009	59

Page 1